Status:
UNKNOWN
Addiction in Adolescence - Pathomechanisms and Treatment Evaluation
Lead Sponsor:
Technische Universität Dresden
Conditions:
Substance Use Disorders
Adolescent Behavior
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
This study aims to investigate the sociodemographic background as well as psychiatric comorbidities of adolescent substance users with substance use disorders. The study simultaneously evaluates bioma...
Detailed Description
As numbers of adolescent drug abuse have grown rapidly within the last couple of years, research on youth drug abuse and dependency has taken a new and vital role within the public healthcare system. ...
Eligibility Criteria
Inclusion
- Adolescents:
- Age 12.00-17.99
- Therapy / wait list group: current substance use disorder
- Controls: no history of substance use disorders
Exclusion
- Preexisting neurological diseases
- Diseases of or with involvement of the central nervous system
- Intelligence quotient (IQ) \< 70
- Diseases concerning the adrenal gland, pituitary gland or hypothalamus
- Acute viral diseases during T0, T1, T2
- Controls:
- Drug intake modulating the central nervous system
- Main psychiatric disorders
- Current substance use
- Parents:
- Inclusion Criteria:
- At least one child/protégé with problematic substance abuse
- No current substance abuse on their own
- At least one parent must be eligible to participate in the group
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03444974
Start Date
August 1 2018
End Date
December 31 2021
Last Update
April 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital C.G.Carus
Dresden, Saxony, Germany, 01307